Your browser doesn't support javascript.
loading
Task-Specific Design of Immune-Augmented Nanoplatform to Enable High-Efficiency Tumor Immunotherapy.
Zhang, Jing; Zhang, Di; Li, Qian; Jiang, Yue; Song, Aixin; Li, Zhonghao; Luan, Yuxia.
Afiliação
  • Zhang J; Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences , Shandong University , 44 Wenhuaxi Road , Jinan , Shandong Province 250012 , China.
  • Zhang D; Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences , Shandong University , 44 Wenhuaxi Road , Jinan , Shandong Province 250012 , China.
  • Li Q; Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences , Shandong University , 44 Wenhuaxi Road , Jinan , Shandong Province 250012 , China.
  • Jiang Y; Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences , Shandong University , 44 Wenhuaxi Road , Jinan , Shandong Province 250012 , China.
  • Song A; Key Laboratory of Colloid & Interface Chemistry (Ministry of Education) , Shandong University , Jinan , Shandong Province 250100 , China.
  • Li Z; Key Laboratory of Colloid & Interface Chemistry (Ministry of Education) , Shandong University , Jinan , Shandong Province 250100 , China.
  • Luan Y; Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences , Shandong University , 44 Wenhuaxi Road , Jinan , Shandong Province 250012 , China.
ACS Appl Mater Interfaces ; 11(46): 42904-42916, 2019 Nov 20.
Article em En | MEDLINE | ID: mdl-31657540

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Resistência a Múltiplos Medicamentos / Resistencia a Medicamentos Antineoplásicos / Materiais Biomiméticos / Nanopartículas / Imunoterapia / Indóis / Neoplasias Mamárias Experimentais Limite: Animals Idioma: En Revista: ACS Appl Mater Interfaces Assunto da revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Resistência a Múltiplos Medicamentos / Resistencia a Medicamentos Antineoplásicos / Materiais Biomiméticos / Nanopartículas / Imunoterapia / Indóis / Neoplasias Mamárias Experimentais Limite: Animals Idioma: En Revista: ACS Appl Mater Interfaces Assunto da revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos